inter-alpha inhibitor protein therapy (ProThera Biologics/Takeda Pharmaceutical)

N/A

Report date: 2025/03/20 16:04:13

Base Information

Drug Nameinter-alpha inhibitor protein therapy (ProThera Biologics/Takeda Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProThera Biologics LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A